William R Kem Selected Research

1,4- diazabicyclo(3.2.2)nonan- 4- yl(5- (3- (trifluoromethyl)phenyl)furan- 2- yl)methanone

1/2021

Therapeutic efficacy of α7 ligands after acute ischaemic stroke is linked to conductive states of α7 nicotinic ACh receptors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

William R Kem Research Topics

Disease

9	Schizophrenia (Dementia Praecox) 01/2018 - 06/2004
4	Inflammation (Inflammations) 01/2021 - 01/2017
3	Burns 01/2021 - 01/2017
3	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 03/2009
2	Ischemic Stroke 01/2021 - 01/2021
2	Brain Injuries (Brain Injury) 01/2021 - 01/2021
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021
1	Pain (Aches) 01/2021
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2021
1	Hyperalgesia 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Neuroinflammatory Diseases 01/2021
1	Atrophic Muscular Disorders 11/2018
1	Neuroblastoma 01/2018
1	Cognitive Dysfunction 01/2018
1	Body Weight (Weight, Body) 01/2017
1	Autism Spectrum Disorder 12/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2013
1	Scoliosis 05/2010
1	Torticollis (Wryneck) 05/2010
1	Lordosis 05/2010
1	Cleft Palate (Palate, Cleft) 05/2010
1	Hemolysis 06/2009
1	Contracture 08/2004

Drug/Important Bio-Agent (IBA)

8	3-(2,4-dimethoxybenzylidene)anabaseineIBA 01/2021 - 06/2010
7	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2021 - 06/2004
6	Cholinergic ReceptorsIBA 01/2021 - 03/2010
4	Nicotinic AgonistsIBA 01/2018 - 06/2006
3	Pharmaceutical PreparationsIBA 12/2016 - 03/2010
2	3- (4- hydroxy- 2- methoxybenzylidene)anabaseineIBA 01/2021 - 01/2021
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2017
2	Therapeutic UsesIBA 01/2021 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2011
2	LigandsIBA 01/2021 - 01/2021
2	CytokinesIBA 01/2021 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2017
2	salicylhydroxamic acid (SHAM)IBA 11/2018 - 01/2017
2	alpha7 Nicotinic Acetylcholine ReceptorIBA 01/2018 - 06/2006
2	Biological ProductsIBA 07/2013 - 06/2004
2	Nicotine FDA Link 06/2006 - 06/2004
1	Messenger RNA (mRNA)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	1- (5- chloro- 2,4- dimethoxyphenyl)- 3- (5- methylisoxazol- 3- yl)ureaIBA 01/2021
1	NF-kappa B (NF-kB)IBA 01/2021
1	CalciumIBA 01/2021
1	AutoantibodiesIBA 01/2021
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2021
1	methyllycaconitineIBA 01/2021
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2021
1	InterleukinsIBA 01/2021
1	1,4- diazabicyclo(3.2.2)nonan- 4- yl(5- (3- (trifluoromethyl)phenyl)furan- 2- yl)methanoneIBA 01/2021
1	MethemoglobinIBA 11/2018
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2018
1	Delayed-Action PreparationsIBA 01/2018
1	Amyloid (Amyloid Fibrils)IBA 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2017
1	Insulin (Novolin)FDA Link 01/2017
1	PolymersIBA 07/2013
1	SaltsIBA 07/2013
1	poly-APSIBA 07/2013
1	AlkaloidsIBA 05/2010
1	Colloids (Colloid)IBA 06/2009
1	S 24795IBA 03/2009
1	SmokeIBA 06/2006
1	Antipsychotic Agents (Antipsychotics)IBA 06/2006
1	CarbonIBA 08/2004
1	Carbachol (Carbastat)FDA Link 08/2004
1	gamma-Aminobutyric Acid (GABA)IBA 06/2004
1	Cholinergic Agents (Cholinergics)IBA 06/2004

Therapy/Procedure

1	Splenectomy 01/2021